-
Shoppers Can Soon Fast-Charge EVs At Malls Thanks To Mercedes-Benz, Federal Realty Deal
Wednesday, July 9, 2025 - 10:58am | 475Read More...Federal Realty Investment Trust (NYSE:FRT) announced a strategic partnership Wednesday with Mercedes-Benz High-Power Charging, naming the automaker its preferred EV charging provider. The collaboration aims to deploy over 500 ultra-fast charging stalls across at least 50 of Federal’s open-air...
-
Snowflake Stock Jumps 45% In 2025 As AI Data Cloud Drives Record Revenue
Wednesday, July 9, 2025 - 10:55am | 980Read More...Snowflake Inc. (NYSE:SNOW), an AI data cloud company, is experiencing significant upward momentum, with its stock trading near its 52-week high of $226.60 and well above its 50-day moving average of $197.41. This surge is fueled by a combination of strong financial performance, strategic product...
-
FDA Approves New Dosing Schedule For Eli Lilly's Kisunla In Alzheimer's Treatment
Wednesday, July 9, 2025 - 9:49am | 636Read More...The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s (NYSE:LLY) Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA...
-
What's Going On With IonQ Stock Today?
Wednesday, July 9, 2025 - 9:21am | 465Read More...IonQ, Inc. (NYSE:IONQ) shares saw modest gains in premarket trading on Wednesday following the company’s announcement of its involvement in a major South Korean quantum computing initiative. The U.S.-based quantum computing firm has been selected as the core technology provider for a newly...
-
Plug Power Extends Key Hydrogen Partnership, Powering Future Growth Through 2030
Wednesday, July 9, 2025 - 9:11am | 341Read More...Plug Power Inc. (NASDAQ:PLUG) announced Wednesday it has renewed and expanded a multi-year hydrogen supply agreement with a longtime U.S.-based industrial gas partner, extending their collaboration through 2030. Under the new deal, the partner will continue providing liquid hydrogen at reduced...
-
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
Wednesday, July 9, 2025 - 9:03am | 689Read More...Merck & Co. Inc. (NYSE:MRK) agreed on Wednesday to acquire Verona Pharma plc (NASDAQ:VRNA) for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma. Through the acquisition of this...
-
This Palantir Partnership Uses AI And Satellites To Predict Weather Like Never Before - Here's What It Means
Wednesday, July 9, 2025 - 8:40am | 635Read More...Palantir Technologies Inc. (NASDAQ:PLTR) shares are trading relatively flat in the premarket session on Tuesday. The company has teamed up with Tomorrow.io, a weather analytics and resilience firm, to bring AI-driven weather insights into its suite of decision-making platforms. The collaboration...
-
Vertical Aerospace's $60 Million Share Offering Sends Shares Crashing
Wednesday, July 9, 2025 - 8:32am | 414Read More...Vertical Aerospace Ltd. (NYSE:EVTL) on Tuesday announced a public offering to raise $60 million through the sale of ordinary shares, sending its stock lower as investors reacted to dilution concerns and financial uncertainty. Proceeds from the raise will fund continued aircraft development,...
-
Why Is Alvotech Stock Trading Higher On Wednesday?
Wednesday, July 9, 2025 - 8:11am | 505Read More...Alvotech (NASDAQ:ALVO) shares saw a positive lift Wednesday morning following the announcement that the biosimilar developer has significantly bolstered its production capabilities by acquiring Swiss pharmaceutical assembly and packaging specialist Ivers-Lee Group. The move boosts Alvotech’s...
-
UnitedHealth Former Staff Reveal Dark Secrets Of Medicare Billing Practices
Wednesday, July 9, 2025 - 7:53am | 735Read More...The U.S. Department of Justice’s (DOJ) criminal healthcare-fraud unit has intensified its investigation into UnitedHealth Group Inc’s (NYSE:UNH) Medicare billing practices, focusing on how it leveraged doctors and nurses to boost government payments. The probe began at least a year ago...
-
Starbucks Attracts $10 Billion In Bids For China Unit Amid Rising Competition
Wednesday, July 9, 2025 - 7:24am | 454Read More...Starbucks Corp. (NASDAQ:SBUX) is reportedly attracting strong investor interest in its China unit, with potential stake valuations reaching up to $10 billion. CNBC reports that close to 30 private equity firms, both domestic and international, have submitted non-binding bids for a stake in...
-
Alibaba Predicts AI Digital Colleagues Will Be Commonplace Within Five Years
Wednesday, July 9, 2025 - 6:34am | 855Read More...In a bold projection that paints a picture of tomorrow’s workforce, Chinese tech giant Alibaba Group Holding (NYSE:BABA) anticipates that AI-powered “digital colleagues” will be an everyday reality within the next five years. This isn’t just a futuristic fantasy; it’s...
-
Super Micro Accelerates European Footprint To Meet Exploding AI Needs
Wednesday, July 9, 2025 - 5:50am | 883Read More...Super Micro Computer, Inc. (NASDAQ:SMCI), a leading AI server manufacturer, plans to increase its investment in Europe to meet surging demand for AI infrastructure. European Expansion Driven By Soaring AI Demand The company, which already operates manufacturing facilities in the Netherlands, is...
-
Why CoreWeave's $9 Billion Deal Isn't About Chips
Tuesday, July 8, 2025 - 3:11pm | 629Read More...CoreWeave, Inc. (NASDAQ:CRWV), an AI cloud-computing startup specializing in AI infrastructure, announced on July 7 its intent to acquire crypto miner Core Scientific, Inc. (NASDAQ:CORZ) in a $9 billion all-stock deal. This acquisition is expected to enable CoreWeave to verticalize its data center...
-
Artelo Biosciences Analyst See It As An Emerging Biotech
Tuesday, July 8, 2025 - 3:06pm | 524Read More...D. Boral Capital upgraded Artelo Biosciences, Inc. (NASDAQ:ARTL) on Tuesday. The analyst upgraded from Hold to Buy and introduced a price forecast of $20. Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced...
















